中华急诊医学杂志
中華急診醫學雜誌
중화급진의학잡지
CHINESE JOURNAL OF EMERGENCY MEDICINE
2013年
12期
1374-1378
,共5页
葛许华%喻文亮%陈俊%赵劭懂%张琴%肖岳%缪红军%王晓榕
葛許華%喻文亮%陳俊%趙劭懂%張琴%肖嶽%繆紅軍%王曉榕
갈허화%유문량%진준%조소동%장금%초악%무홍군%왕효용
血浆置换%连续血液净化%人工肝%非生物型人工肝%急性肝衰竭%多器官功能障碍综合征%治疗%儿童
血漿置換%連續血液淨化%人工肝%非生物型人工肝%急性肝衰竭%多器官功能障礙綜閤徵%治療%兒童
혈장치환%련속혈액정화%인공간%비생물형인공간%급성간쇠갈%다기관공능장애종합정%치료%인동
PE%CVVHDF%Artificial liver%Non-biotype artificial liver%ALF%MODS%Treatment%Children
目的 回顾性分析南京医科大学附属南京儿童医院2年来使用治疗性血浆置换联合连续静-静脉血液滤过+透析方法在16例急性肝衰竭儿童中的应用,探讨非生物型人工肝支持系统对儿童急性肝衰竭的治疗作用.方法 收集201 1年4月至2013年3月南京医科大学附属南京儿童医院PICU住院治疗的急性肝衰竭患儿16例,自入院开始,按需要给予降酶、退黄、抗感染、机械通气、血管活性药物等内科综合治疗;符合急性肝衰竭诊断标准后,立即给予非生物型人工肝治疗,以开始血液净化治疗作为0点,在0、1、2、3、5和7d时点抽取静脉血行血生化、凝血常规检查,比较其在不同时点的谷丙转氨酶(ALT)的水平,总胆红素(TBIL)、凝血酶原时间(PT)、尿素氮(BUN)、肌酐(Cr),在治疗的0d、3d二个时点抽取静脉血行甲胎蛋白(AFP)检测.计量资料采用均数±标准差(x±s)表示,治疗前后组内两均数间进行方差分析.结果 16例患儿均行非生物型人工肝治疗,血浆置换时间(7.25±2.25)h,连续血液滤过(+透析)时间(120.75 ±33.45)h.其中治愈出院12例,死亡2例,自动出院2例.治疗2dALT水平明显下降、凝血酶原活动度(PTA)明显上升,3dPT明显改善,Cr、TBIL水平明显下降,5 d BUN水平明显下降.结论 与传统内科保守治疗相比,治疗性血浆置换联合连续静-静脉血液透析+滤过的非生物型人工肝支持系统能明显改善急性肝衰竭患儿的肝肾功能及凝血功能,改善预后.
目的 迴顧性分析南京醫科大學附屬南京兒童醫院2年來使用治療性血漿置換聯閤連續靜-靜脈血液濾過+透析方法在16例急性肝衰竭兒童中的應用,探討非生物型人工肝支持繫統對兒童急性肝衰竭的治療作用.方法 收集201 1年4月至2013年3月南京醫科大學附屬南京兒童醫院PICU住院治療的急性肝衰竭患兒16例,自入院開始,按需要給予降酶、退黃、抗感染、機械通氣、血管活性藥物等內科綜閤治療;符閤急性肝衰竭診斷標準後,立即給予非生物型人工肝治療,以開始血液淨化治療作為0點,在0、1、2、3、5和7d時點抽取靜脈血行血生化、凝血常規檢查,比較其在不同時點的穀丙轉氨酶(ALT)的水平,總膽紅素(TBIL)、凝血酶原時間(PT)、尿素氮(BUN)、肌酐(Cr),在治療的0d、3d二箇時點抽取靜脈血行甲胎蛋白(AFP)檢測.計量資料採用均數±標準差(x±s)錶示,治療前後組內兩均數間進行方差分析.結果 16例患兒均行非生物型人工肝治療,血漿置換時間(7.25±2.25)h,連續血液濾過(+透析)時間(120.75 ±33.45)h.其中治愈齣院12例,死亡2例,自動齣院2例.治療2dALT水平明顯下降、凝血酶原活動度(PTA)明顯上升,3dPT明顯改善,Cr、TBIL水平明顯下降,5 d BUN水平明顯下降.結論 與傳統內科保守治療相比,治療性血漿置換聯閤連續靜-靜脈血液透析+濾過的非生物型人工肝支持繫統能明顯改善急性肝衰竭患兒的肝腎功能及凝血功能,改善預後.
목적 회고성분석남경의과대학부속남경인동의원2년래사용치료성혈장치환연합련속정-정맥혈액려과+투석방법재16례급성간쇠갈인동중적응용,탐토비생물형인공간지지계통대인동급성간쇠갈적치료작용.방법 수집201 1년4월지2013년3월남경의과대학부속남경인동의원PICU주원치료적급성간쇠갈환인16례,자입원개시,안수요급여강매、퇴황、항감염、궤계통기、혈관활성약물등내과종합치료;부합급성간쇠갈진단표준후,립즉급여비생물형인공간치료,이개시혈액정화치료작위0점,재0、1、2、3、5화7d시점추취정맥혈행혈생화、응혈상규검사,비교기재불동시점적곡병전안매(ALT)적수평,총담홍소(TBIL)、응혈매원시간(PT)、뇨소담(BUN)、기항(Cr),재치료적0d、3d이개시점추취정맥혈행갑태단백(AFP)검측.계량자료채용균수±표준차(x±s)표시,치료전후조내량균수간진행방차분석.결과 16례환인균행비생물형인공간치료,혈장치환시간(7.25±2.25)h,련속혈액려과(+투석)시간(120.75 ±33.45)h.기중치유출원12례,사망2례,자동출원2례.치료2dALT수평명현하강、응혈매원활동도(PTA)명현상승,3dPT명현개선,Cr、TBIL수평명현하강,5 d BUN수평명현하강.결론 여전통내과보수치료상비,치료성혈장치환연합련속정-정맥혈액투석+려과적비생물형인공간지지계통능명현개선급성간쇠갈환인적간신공능급응혈공능,개선예후.
Objective To explore the therapeutic effect of non-biotype artificial liver support system (NBALSS) in acute liver failure (ALF) of children by analyzing the data of 16 children with ALF treated with plasma exchange (PE) and continuous venovenous hemodiafiltration (CVVHDF) in the past 2 years.Methods A total of 16 children with ALF in PICU admitted from April 2011 to March 2013 were enrolled in this study.After admission,they were treated for lowering transaminase,removing jaundice,antiinfection,maintaining respiration with mechanic ventilation support and maintaining blood pressure with vasoactive drugs.When patients met the criteria of ALF,the NBALSS was initiated.The CVVHDF were scheduled on the day of admission,and blood chemistry and routine coagulation were checked on the day of admission,day 1,2,3,5 and 7 after NBALSS.The levels of alanine aminotransferase (ALT),total bilirubin (TBIL),prothrombin time (PT),blood urea nitrogen (BUN) and creatinine (Cr) were compared between before and after NBALSS.Alpha-fetoprotein (AFP) was checked on day of admission and 3 days after NBALSS.The data was expressed with Y ± s,and analysis of variance was used for data analysis before and after treatment.Results In 16 ALF children treated with NBALSS,PE time was (7.25 ± 2.25) h,and CVVHDF time was (120.75 ± 33.45) h.On day 2,ALT levels significantly decreased and prothrombin activity (PTA) significantly improved.From day 3,PT significantly shortened,and Cr and TBIL level significantly decreased.On day 5,BUN level decreased significantly.Of them,12 children survived,2 chindren died and 2 children got off from hospital by their own parent decision.Conclusions Compared with conventionally conservative treatment,non-biotype artificial liver support system can improve liver and kidney function and coagulation of ALF children more efficiently,thereby improving the outcome of patients.